The Future of Artificial Intelligence

Matt Middleston: We need to shift our focus from promoting R&D and investing in research. He says we should also look at how institutions are inhibiting the adoption of these technologies. The FDA that can only approve 23 new drugs a year is probably not suited for an AI deluge, he says.